| Patients with early BRONJ and bone exposure via fistulas |
| D.M. |
f |
60 |
27.05.10 |
BC |
Zol |
Stage 0 region 36 |
Desinfectant rinsing, LLLT |
Mucosal healing |
| S.R. |
f |
57 |
23.02.10 |
BC |
Zo |
Stage 0 region 44-45 |
Desinfectant rinsing, LLLT |
Mucosal healing |
| Sc.E. |
f |
48 |
25.03.10 |
BC |
Zo |
Stage 0 (pus) region 37, 27 |
Desinfectant rinsing, LLLT |
Mucosal healing |
| St.E. |
f |
51 |
10.05.10 |
BC |
Zo |
Stage 0 region 46 |
Desinfectant rinsing, LLLT |
Mucosal healing |
| vH.W. |
f |
54 |
23.02.10 |
BC |
Zo |
Stage 0 (pus) region 47 |
Desinfectant rinsing, LLLT |
Mucosal healing |
| Patients with impaired healing after BRONJ surgery |
| B.T. |
f |
69 |
17.08.10 |
OP |
Al |
Stage 2, 35-38, |
Er:YAG Surgery 18.10.10; Dehiscence 10 days after surgery → LLLT |
Mucosal healing |
| C.E. |
f |
65 |
31.05.11 |
BC |
Zo |
Stage 2, 35-38 lingually |
Er:YAG Surgery 18.07.11
Dehiscence 38 PDprogredient |
No success |
| D.A. |
f |
86 |
26.06.07 |
MM |
Zo |
Stage 2, region 44-45 |
ErCrYSGG Surgery 13.01.09; Postoperative dehiscence → LLLT |
Mucosal healing |
| H.W. |
m |
69 |
22.11.10 |
PC |
Zo |
Stage 3, region 45 |
Er:YAG surgery 07.03.11
Fistula |
No success |
| K.M. |
f |
74 |
05.10.10 |
BC |
Zo |
Stage (0) 2, 46-47 |
Er:YAG Surgery 23.05.11; Dehiscence 10 days after surgery → LLLT |
Mucosal healing |
| S.E. |
f |
68 |
30.07.10 |
BC |
Zo |
Stage 2, region 16-17 |
Er:YAG Surgery 17.1.11; Dehiscence 10 days after surgery → LLLT |
Mucosal healing - 1 month |
| S.W. |
f |
66 |
03.08.10 |
BC |
Zo→Ib |
Stage (0) 2, region 13 |
Er:YAG Surgery 28.02.11; Dehiscence 10 days after surgery → LLLT |
Mucosal healing |
Pat: Patient; S: Sex; m: male; f: female; PD: Primary disease; BC: Breast cancer; BrC: Bronchial Carcinoma; MM: Multiple Myeloma; PC: Prostate cancer; OP: Osteoporosis;
BP: Bisphosphonate; Zo: Zoledronate; Ib: Ibandronate; Al: Alendronate; CMT: conservative maintenance therapy; Tooth numbering: World Dental Federation notation